Smallpox vaccination grinds to halt

A PLAN to vaccinate nearly half a million healthcare workers in the US against smallpox in case of a bioterrorist attack has ground to a halt. Only 38,257 people have accepted vaccination, less than a tenth as many as planned.

But the failure may run deeper. In a damning report released last week, the US Institute of Medicine, an independent advisory body, says the problem is not that so few have been vaccinated, but that so much time and money has been spent on the vaccination programme. It argues that this should have been spent on more important defensive measures such as disease surveillance and response plans.

"There are many things more important than vaccinating people," says Brian Strom of the University of Pennsylvania, lead author of the report. "We have no idea if we're prepared for a bioterrorist attack." He cites the failure by doctors in Wisconsin to report cases of a disease similar to smallpox until 13 days after they saw the first rash (New Scientist, 21 June, p 12). Luckily, it turned out to be monkeypox.

The vaccination programme was announced by President Bush last December. The first phase was to be mandatory smallpox vaccinations for half a million military personnel, and voluntary vaccinations for another half a million "first responders"- the healthcare workers needed to carry out emergency vaccination and treat victims during an outbreak. That number was derived by multiplying the 2000-odd emergency rooms in the US by the staff needed to run them, says D. A. Henderson of Johns Hopkins University in Baltimore, who led the successful worldwide smallpox eradication campaign in the 1970s and helped devise the US plan. "State health officers counted 420,000 people they would want to vaccinate to provide some reasonable standard of emergency care."

But doctors and nurses stayed away in droves. The vaccine is a live virus that can spread from person to person and might have harmed patients, especially those with im

Contact: Claire Bowles
New Scientist

Page: 1 2 3

Related biology news :

1. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
2. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
3. CDC Telebriefing: Smallpox educational activities and West Nile Virus update
4. Smallpox vaccines
5. OHSU researchers publish final results of groundbreaking smallpox vaccination study
6. Measles on the rise as vaccinations fall in the UK, Science study reports
7. Rabies vaccinations could help save Ethiopian wolf
8. Study examines the potential risks of smallpox vaccination
9. Association found between anthrax vaccination, medication and health problems of Gulf War veterans
10. Dendritic cell-based vaccination to prevent opportunistic fungal infections
11. DNA vaccination places tumors in double jeopardy

Post Your Comments:

(Date:11/11/2019)... ... November 11, 2019 , ... MicroGenDX, the world leader in ... in the award-winning study “Next Generation Sequencing for the Diagnosis of Periprosthetic Knee ... processed samples using Next Generation DNA Sequencing to examine the ability of NGS ...
(Date:11/6/2019)... Va. (PRWEB) , ... November 06, 2019 , ... ... today that Donald Stanski, MD, a senior pharmaceutical industry executive with expertise in ... and simulation for drug and disease strategic data analytics, has joined the firm ...
(Date:11/5/2019)... WA (PRWEB) , ... November 05, 2019 , ... ... & Amato Dentistry, providing state-of-the-art cosmetic and restorative dentistry to Seattle, WA, including ... her Doctor of Dental Surgery degree from the University of Washington, Dr. Kopp ...
Breaking Biology News(10 mins):
(Date:11/27/2019)... ... November 25, 2019 , ... Silony Medical, a medical ... and navigated surgery in the UK. The procedure was performed in the UK’s ... Syed Aftab and Dr. Alexander Montgomery. The surgery, which took place on July ...
(Date:11/20/2019)... ... November 20, 2019 , ... Defense and ... microturbine electrical power generation units from 2019-2028. The value of this production is ... of 3,821 units worth $569 million. , Reference to 2017 is important, ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... R&D, today announced that Immatics Biotechnologies , a clinical-stage biopharmaceutical company ... to streamline their R&D operations related to the discovery and development of ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... to educate Americans about the deadly healthcare-associated infection C. diff. The campaign, ... of the epidemic, which kills at least 30,000 people in the U.S. each ...
Breaking Biology Technology:
Cached News: